Paul Frankel

Also affiliated with Beckman Research Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma”.

Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma

JAMA Oncology(2021)10.1001/jamaoncol.2021.3441

N/A

1.6DataRank · unranked

45 citations

Paul Frankel, Amir Mortazavi, Matthew I. Milowsky, Ulka N. Vaishampayan, Mamta Parikh +15 more

Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002084

N/A

1.3DataRank · unranked

32 citations

Weihua Guo, Susan E. Yost, Jin Sun Lee, D. L. ROSE, Christian Avalos +7 more

Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03470-y

N/A

0.809DataRank · unranked

22 citations

Weihua Guo, Susan E. Yost, Xuan Ge, Jin Sun Lee, Paul Frankel +12 more

Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878)

Clinical Lung Cancer(2021)10.1016/j.cllc.2021.05.001

N/A

0.789DataRank · unranked

18 citations

Karen L. Reckamp, Paul Frankel, Jeff Longmate, Karen A. Kelly, David R. Gandara +7 more

Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer

The Oncologist(2023)10.1093/oncolo/oyad026

N/A

0.580DataRank · unranked

14 citations

Susan E. Yost, Yujie Cui, Christopher Ruel, Mireya Murga, Aileen Tang +10 more

Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast Cancer

The Oncologist(2020)10.1002/onco.13574

N/A

0.568DataRank · unranked

43 citations

Jin Sun Lee, Susan E. Yost, Sierra Min Li, Paul Frankel, Christopher Ruel +17 more

Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing Malignancies

Cancer Biotherapy and Radiopharmaceuticals(2020)10.1089/cbr.2019.2992

N/A

0.505DataRank · unranked

28 citations

Paul J. Yazaki, Dave Yamauchi, Jennifer Simpson, Paul Frankel, James R. Bading +9 more

Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer

Cancers(2022)10.3390/cancers14174279

N/A

0.385DataRank · unranked

12 citations

Susan E. Yost, Jin Sun Lee, Paul Frankel, Christopher Ruel, Yujie Cui +13 more

Phase I study of TRC102 in combination with cisplatin and pemetrexed in patients with advanced solid tumors/Phase II study of TRC102 with pemetrexed in patients with mesothelioma refractory to pemetrexed and cisplatin or carboplatin.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9055

N/A

0.104DataRank · unranked

1 citations

Paul Frankel, Jonathan W. Riess, Anthony B. El-Khoueiry, Liza C. Villaruz, Stephen Leong +5 more

A randomized phase II study comparing cisplatin and gemcitabine with or without berzosertib in patients with advanced urothelial carcinoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4507

N/A

0.104DataRank · unranked

1 citations

Amir Mortazavi, Matthew I. Milowsky, Ulka N. Vaishampayan, Mamta Parikh, Yung Lyou +15 more

The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404)

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0305

N/A

0.104DataRank · unranked

1 citations

Nataliya V. Uboha, Naoko Takebe, Kit Tam, Philippe L. Bédard, Kari B. Wisinski +13 more

A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis

Blood Advances(2025)10.1182/bloodadvances.2025016845

N/A

0DataRank · unranked

2 citations

Tamer Othman, Paul Frankel, Christopher Ruel, Christina Poh, Samantha Herbert +20 more

Model of a Queuing Approach for Patient Accrual in Phase 1 Oncology Studies

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.4787

N/A

0DataRank · unranked

16 citations

Vincent Chung, Joseph M. Tuscano, Tanya Siddiqi, Sagus Sampath, Jeff Longmate +3 more

TMLI and Skin Irradiation as Conditioning Regimens for Allogeneic Hematopoietic Cell Transplant in T-Cell Lymphoma Patients

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.06.3135

N/A

0DataRank · unranked

0 citations

Anxiang Wen, Claire Hao, Colton Ladbury, Paul Frankel, Oluwatimilehin Okunowo +15 more

Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis

PLoS ONE(2020)10.1371/journal.pone.0229955

N/A

0DataRank · unranked

33 citations

Susan E. Yost, Paul Frankel, Andrew Dagis, Yu Cao, Roger Wang +8 more

Repeatability of tumor perfusion kinetics from dynamic contrast-enhanced MRI in glioblastoma

Neuro-Oncology Advances(2021)10.1093/noajnl/vdab174

N/A

0DataRank · unranked

12 citations

Prativa Sahoo, Yujie Cui, Bihong T. Chen, Mark S. Shiroishi, Cristina Lavini +6 more

A Phase 2 Trial Combining Pembrolizumab and Palliative Radiation Therapy in Gastroesophageal Cancer to Augment Abscopal Immune Responses

Advances in Radiation Oncology(2021)10.1016/j.adro.2021.100807

N/A

0DataRank · unranked

9 citations

Ting-Fang He, Massimo D’Apuzzo, Yi‐Jen Chen, Paul Frankel, Michael Tajon +6 more

Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human Primates

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.15.460487

N/A

0DataRank · unranked

6 citations

Vu H. Nguyen, Yoonsuh Park, Heidi Contreras, Veronica Karpinski, Katelyn Faircloth +16 more

Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates

npj Vaccines(2022)10.1038/s41541-022-00436-6

N/A

0DataRank · unranked

64 citations

Vu H. Nguyen, Yoonsuh Park, Heidi Contreras, Veronica Karpinski, Katelyn Faircloth +16 more

Explicit underdose control based on toxicity: Four points to consider

Statistics in Medicine(2022)10.1002/sim.9492

N/A

0DataRank · unranked

1 citations

Elizabeth Garrett‐Mayer, Mark Krailo, Paul Frankel

Mechanism-Driven and Clinically Focused Development of Botanical Foods as Multitarget Anticancer Medicine: Collective Perspectives and Insights from Preclinical Studies, IND Applications and Early-Phase Clinical Trials

Cancers(2023)10.3390/cancers15030701

N/A

0DataRank · unranked

18 citations

Yin Chan, Kelly Wong, Ryohei Yoshitake, David Sadava, Timothy W. Synold +5 more

Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian Cancer

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0394

N/A

0DataRank · unranked

4 citations

Paul Frankel, Mihaela Cristea, Melissa Eng, Raechelle Tinsley, Shannon Dempsey +5 more

Order of patient entry and outcomes in phase II clinical trials: A meta-analysis of individual patient data

Contemporary Clinical Trials(2023)10.1016/j.cct.2023.107083

N/A

0DataRank · unranked

0 citations

Miguel A. Villalona‐Calero, Edward M. Newman, Paul Frankel, Carolyn E. Behrendt

Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I Trial

Annals of Surgical Oncology(2025)10.1245/s10434-025-18432-0

N/A

0DataRank · unranked

4 citations

Rosemary Senguttuvan, Nora Ruel, Paul Frankel, Susan E. Yost, Sarah Cole +16 more